Cargando…

microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer

BACKGROUND: N-Myc Interactor is an inducible protein whose expression is compromised in advanced stage breast cancer. Downregulation of NMI, a gatekeeper of epithelial phenotype, in breast tumors promotes mesenchymal, invasive and metastatic phenotype of the cancer cells. Thus the mechanisms that re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rostas, Jack W, Pruitt, Hawley C, Metge, Brandon J, Mitra, Aparna, Bailey, Sarah K, Bae, Sejong, Singh, Karan P, Devine, Daniel J, Dyess, Donna L, Richards, William O, Tucker, J Allan, Shevde, Lalita A, Samant, Rajeev S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169820/ https://www.ncbi.nlm.nih.gov/pubmed/25174825 http://dx.doi.org/10.1186/1476-4598-13-200

Ejemplares similares

N-Myc and STAT Interactor regulates autophagy and chemosensitivity in breast cancer cells
por: Metge, Brandon J., et al.
Publicado: (2015)

Loss of N-Myc interactor promotes epithelial-mesenchymal-transition by activation of TGF-β/SMAD signaling
por: Devine, Daniel J., et al.
Publicado: (2013)

Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors
por: Pruitt, Hawley C., et al.
Publicado: (2018)

Roles of N‐Myc and STAT interactor in cancer: From initiation to dissemination
por: Pruitt, Hawley C., et al.
Publicado: (2016)

Micro-RNA-632 down regulates DNAJB6 in breast cancer
por: Mitra, Aparna, et al.
Publicado: (2012)

Hypoxia re-programs 2′-O-Me modifications on ribosomal RNA
por: Metge, Brandon J., et al.
Publicado: (2020)

NMI and EMT
por: Samant, Rajeev S., et al.
Publicado: (2014)

Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299–5p regulated de novo expression of osteopontin
por: Shevde, Lalita A, et al.
Publicado: (2010)

Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumors
por: Alsheikh, Heba Allah M., et al.
Publicado: (2021)

Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance
por: Elhamamsy, Amr R., et al.
Publicado: (2022)

Recent Advances in Anti-Angiogenic Therapy of Cancer
por: Samant, Rajeev S., et al.
Publicado: (2011)

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer
por: Mitra, Aparna, et al.
Publicado: (2008)

Merlin deficiency alters the redox management program in breast cancer
por: Mota, Mateus, et al.
Publicado: (2021)

Hedgehog Signaling in Tumor Cells Facilitates Osteoblast-Enhanced Osteolytic Metastases
por: Das, Shamik, et al.
Publicado: (2012)

Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer
por: Hanna, Ann, et al.
Publicado: (2018)

Hedgehog signaling enables repair of ribosomal DNA double-strand breaks
por: Lama-Sherpa, Tshering D, et al.
Publicado: (2020)

The Hedgehog Pathway Conditions the Bone Microenvironment for Osteolytic Metastasis of Breast Cancer
por: Das, Shamik, et al.
Publicado: (2012)

Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer
por: Meng, Erhong, et al.
Publicado: (2016)

Retraction: Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer
por: Meng, Erhong, et al.
Publicado: (2023)

The Impact of Hedgehog Signaling Pathway on DNA Repair Mechanisms in Human Cancer
por: Meng, Erhong, et al.
Publicado: (2015)

Novel role of the dietary flavonoid fisetin in suppressing rRNA biogenesis
por: Kammerud, Sarah C., et al.
Publicado: (2021)

Sulindac inhibits tumor cell invasion by suppressing NF-κB mediated transcription of microRNAs
por: Li, Xiaobo, et al.
Publicado: (2012)

Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer
por: Morrow, K. Adam, et al.
Publicado: (2016)

Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling
por: Das, Shamik, et al.
Publicado: (2017)

Ribosome biosynthesis and Hedgehog activity are cooperative actionable signaling mechanisms in breast cancer following radiotherapy
por: Metge, Brandon J., et al.
Publicado: (2023)

The Influence of the Cancer Microenvironment on the Process of Metastasis
por: Frost, Andra R., et al.
Publicado: (2012)

O-GlcNAcylation of GLI Transcription Factors in Hyperglycemic Conditions Augments Hedgehog activity: Hyperglycemic conditions upregulate GLI activity
por: Das, Shamik, et al.
Publicado: (2018)

Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation
por: Samant, Rajeev S, et al.
Publicado: (2007)

INCREASED VASCULARITY AND SPONTANEOUS METASTASIS OF BREAST CANCER BY HEDGEHOG SIGNALING MEDIATED UPREGULATION OF CYR61
por: Harris, Lillianne G., et al.
Publicado: (2011)

Functional characterization of the progestagen-associated endometrial protein gene in human melanoma
por: Ren, Suping, et al.
Publicado: (2010)

Merlin regulates signaling events at the nexus of development and cancer
por: Mota, Mateus, et al.
Publicado: (2020)

Regulation of cytohesins by their interactors in the nervous system
por: Zhai, Yuqi, et al.
Publicado: (2023)

Current Operative Management of Breast Cancer: An Age of Smaller Resections and Bigger Cures
por: Rostas, Jack W., et al.
Publicado: (2012)

Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer
por: Weeks, Shannon E., et al.
Publicado: (2021)

The nucleolus: a central response hub for the stressors that drive cancer progression
por: Weeks, Shannon E., et al.
Publicado: (2019)

BH3 mimetics suppress CXCL12 expression in human malignant peripheral nerve sheath tumor cells
por: Graham, Christopher D., et al.
Publicado: (2016)

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
por: Riker, Adam I, et al.
Publicado: (2008)

Autocrine/paracrine actions of growth hormone in human melanoma cell lines
por: Buckels, Ashiya, et al.
Publicado: (2019)

SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma
por: Saini, Masum, et al.
Publicado: (2018)

BVES is a novel interactor of ANO5 and regulates myoblast differentiation
por: Li, Haiwen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_02qrbb8jdcucbmq196eimodtqu